Identification and characterisation of a novel adhesin Ifp in Yersinia pseudotuberculosis
© Strong et al; licensee BioMed Central Ltd. 2011
Received: 4 January 2011
Accepted: 28 April 2011
Published: 28 April 2011
In order to identify new virulence determinants in Y. pseudotuberculosis a comparison between its genome and that of Yersinia pestis was undertaken. This reveals dozens of pseudogenes in Y. pestis, which are still putatively functional in Y. pseudotuberculosis and may be important in the enteric lifestyle. One such gene, YPTB1572 in the Y. pseudotuberculosis IP32953 genome sequence, encodes a protein with similarity to invasin, a classic adhesion/invasion protein, and to intimin, the attaching and effacing protein from enteropathogenic (EPEC) and enterohaemorraghic (EHEC) Escherichia coli.
We termed YPTB1572 Ifp (Intimin family protein) and show that it is able to bind directly to human HEp-2 epithelial cells. Cysteine and tryptophan residues in the C-terminal region of intimin that are essential for function in EPEC and EHEC are conserved in Ifp. Protein binding occurred at distinct foci on the HEp-2 cell surface and can be disrupted by mutation of a single cysteine residue at the C-terminus of the protein. Temporal expression analysis using lux reporter constructs revealed that ifp is expressed at late log phase at 37°C in contrast to invasin, suggesting that Ifp is a late stage adhesin. An ifp defined mutant showed a reduction in adhesion to HEp-2 cells and was attenuated in the Galleria mellonella infection model.
A new Y. pseudotuberculosis adhesin has been identified and characterised. This Ifp is a new member in the family of invasin/intimin outer membrane adhesins.
Within the genus Yersinia there are three human-pathogenic species; Y. pestis, the causative agent of plague, and two enteric pathogens, Y. pseudotuberculosis and Y. enterocolitica. Despite the differences in disease, Y. pestis and Y. pseudotuberculosis are very closely related at the genetic level. Y. pestis is believed to have evolved from Y. pseudotuberculosis between 1,500-20,000 years ago . Thus, in a remarkably short length of evolutionary time, Y. pestis has evolved from an enteropathogen, to a blood-borne pathogen with an insect vector . Genome sequencing of several Y. pseudotuberculosis and Y. pestis strains, revealed that Y. pestis has accumulated a large number of pseudogenes since its divergence. By the "use it or lose it" paradigm, this is suggestive of the decay of those genes that are no longer required for function as Y. pestis adapts to a new lifestyle [3, 4]. Gene disruption may also result in pathoadaptive mutation, whereby loss of gene function results in an increase in virulence . This has been demonstrated in several pathogenic bacteria including Shigella spp. and Escherichia coli [6, 7]. Pathoadaptive mutations have previously been identified in Y. pestis, with the negative regulators of biofilm formation, rcsA and nghA, being disrupted, resulting in the ability of Y. pestis to form biofilms within the flea vector [8, 9].
Pseudogenes in Y. pestis that are known to be essential for the enteric lifestyle of Y. pseudotuberculosis, include the adhesins YadA and invasin [3, 10, 11]. Invasin was one of the first bacterial virulence factors identified, when it was observed that the inv gene alone was sufficient to convert benign non-invasive laboratory E. coli strains, to being capable of invading tissue culture cells . Invasin is a 103 kDa protein that is capable of binding to β1 integrins on the host cells, promoting internalisation of the bacterium . During early infection, invasin specifically binds β1 integrins on the apical surface of M cells, which facilitates efficient translocation to the underlying Peyer's patches . The invasin protein is composed of a short N-terminal transmembrane domain, four structural bacterial immunoglobulin domains (bIg domains) and a C-type lectin-like domain . The last bIg domain and the C-type lectin-like domain comprise the functional β1 integrin binding region [15, 16].
In the same family of bacterial adhesion proteins as invasin, is intimin, an important adhesin expressed by enteropathogenic (EPEC) and enterohaemorrhagic (EHEC) E. coli on the LEE pathogenicity island . Intimin is a 94 kDa outer membrane protein that is also found in Citrobacter freundii and Hafnia alvei [17, 18]. The functional binding domain of intimin is located in the 280 amino acid C-terminal region, and consists of two bIg domains and a C-type lectin-like domain, which are structurally similar to invasin [15, 18, 19]. When EPEC and EHEC colonise the small intestine mucosa, a characteristic attaching and effacing lesion is formed. First there is localised destruction (effacement) of the microvilli, which leads to intimate attachment of the bacterium to the host cell . EPEC and EHEC encode a specific intimin receptor, translocated intimin receptor (Tir). This receptor is translocated directly into the host cells via a type III secretion system, where it becomes expressed on the cell surface [21, 22]. Intimin binds to Tir leading to its activation, which results in actin polymerisation within the host cell and the formation of a pedestal, facilitating tighter adherence between the host cell and the bacterium [17, 23]. Other eukaryotic receptors have been suggested for intimin, including nucleolin and some β1 integrins, but as yet it is unknown if these interactions have a role in vivo [24, 25].
There is considerable sequence variation between the intimins from different E. coli strains and they have been categorised into different subtypes, each with a high affinity for its own cognate Tir . However, despite this diversity, it has been found that within the C-terminal binding domain there are four tryptophan residues and two cysteine residues, which are conserved between all subtypes [27, 28]. The two cysteines are also conserved in similar locations within the Y. pseudotuberculosis invasin. In both invasin and intimin a disulphide bond is formed, which is essential for the structure of the C-terminal binding domain and therefore required for full functionality [29, 30]. In the instance of invasin, disruption of either cysteine results in an inability to bind to integrin, and therefore is defective for invasion .
Analysis of Y. pseudotuberculosis strain IP32953 sequence data identified a gene encoding a protein with significant amino acid similarity to invasin and intimin, which has not been previously investigated. We have termed this protein Ifp (intimin family protein) and intriguingly it has been mutated to a pseudogene in all seven Y. pestis genomes sequenced to date. Examination of the amino acid sequence of Ifp revealed that three of the four tryptophans and both of the cysteine residues that are important in intimin function are conserved. However, no Tir orthologue can be identified in the IP32953 genome sequence. Given the amino acid similarity of Ifp to both invasin and intimin, coupled with it being putatively non-functional in Y. pestis, we postulated that Ifp may be an adhesin. We demonstrate that Ifp is a functional adhesin that binds to distinct foci on host cells. Expression occurs in late log or early stationary phase at 37°C only and coincides with a decline in the expression of invasin at this temperature.
Strains used and culture conditions
The strains and plasmids used in this study
Strain or plasmid
Y. pseudotuberculosis IP32953
Y. pseudotuberculosis IP32953 ΔIFP
Y. pseudotuberculosis IP32953 ΔINV
Y. pseudotuberculosis IP32953 ΔIFPΔINV
Y. pseudotuberculosis IP32953 ΔIFPpIFP
Y. pseudotuberculosis IP32953 YPTB1572Lux
Y. pseudotuberculosis IP32953 YPTB1668Lux
E. coli TB1 MBP-Ifp
E. coli TB1 MBP-IfpC337G
Construction of lux reporter strains
Primers used in this study
Bioluminescence and optical density of Lux constructs
Bioluminescence and optical density were monitored simultaneously in 96-well microtitre plates using the Anthos Lucy1 combined photometer and luminometer controlled by the Stingray software (Dazdaq). Overnight 30°C cultures of 1572lux and 1668lux were diluted 1:200 in fresh LB with antibiotics and grown for 3-4 h at 30°C. The optical density of the culture was adjusted to a starting OD600 of 0.1 and 200 μl was added to the wells of the 96 well plate. Assays were performed at 24°C, 28°C and 37°C. Luminescence and OD at 405 nm of the cultures was automatically determined every 30 min for 18 h and presented as relative light units per unit of OD405 (light per unit cell). For every promoter fusion assay each sample was assayed in triplicate on the 96-well plate, and each experiment was carried out in duplicate.
Construction of Maltose Binding Protein (MBP) fusion proteins
Primers YptbIntMBP-1 and YptbIntMBP-2 (Table 2) were used to PCR amplify the 3' end (1044 bp) of the ifp coding sequence. This PCR product was cloned into the pMAL-p2x vector (NEB, Hitchin, UK) using EcoRI and XbaI enzyme restriction sites which had been incorporated into the primer design. In order to generate an MBP-Ifp fusion with the terminal cysteine (Cys1070) mutated to a glycine (MBP-IfpC337G), primer YptbIntMBP-3 was substituted for YptbMBP-2. Primer YptbIntMBP-3 contained an alternative sequence (underlined in table 2) to mutate the terminal cysteine to a glycine. MBP-fusion proteins were then expressed in TB1 E. coli.
Purification of MBP-Ifp and MBP-IfpC337G
E. coli transformed with the MBP-fusion plasmids were cultured for 2 h at 37°C using 5 ml of an overnight culture in 250 ml LB broth with 2 mM glucose and ampicillin until a culture growth of OD600 0.5 was reached. Expression of the fusion protein was induced with 0.3 mM isopropyl-β-D-thiogalactoside (IPTG) then the culture was incubated for further 2 hours at 37°C. The cultures were centrifuged and pellets stored overnight at -20°C then resuspended in column buffer (20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA in H2O). The cells were lysed by sonication using a Bioruptor sonicator (Diagenode; 60 second pulses with a 30 second recovery period). Insoluble proteins were removed by centrifugation and the supernatant was applied to 1 ml columns of amylose resin (NEB). After washing with 15 ml column buffer, proteins were eluted with 10 ml column buffer/10 mM maltose. Proteins were concentrated using Amicon ultra 50 kDa columns (Millipore, Watford, UK), and then confirmed by Coomassie staining and western blotting with anti-MBP (NEB). Protein concentrations were determined by Pierce BCA protein assay kit (Rockford, USA) according to the manufacturer's protocol.
Analysis of MBP-fusion protein binding to HEp-2 cells by fluorescence microscopy
Binding of MBP-tagged Ifp was determined by fluorescence microscopy as described previously . HEp-2 cells were cultured overnight on glass coverslips in 24-well plates at 2.5 × 105 cells/well in 1 ml tissue culture media (minimum essential medium eagle (MEM), 10% fetal calf serum (w/v), 2 mM L-glutamine, 100 U penicillin ml-1, 100 μg streptomycin ml-1, MEM non-essential amino acids). The cells were blocked for 30 minutes at 37°C/5% CO2 in 250 μl binding solution (0.4% BSA (w/v), 2.5 mM maltose, 2 mM L-glutamine in RPMI media), then incubated for 45 minutes at 37°C/5% CO2 with 250 μl MBP-Ifp, MBP-IfpC337G or MBP protein alone (NEB) at 100 μg ml-1 in binding solution. The cells were washed 5 times with 1 ml PBS/1% BSA (w/v) and incubated for 30 minutes at 37°C/5% CO2 in 250 μl of a 1:1000 dilution of rabbit anti-MBP antibody (NEB) in binding solution used. Cells were washed 5 times with 1 ml PBS/1% BSA (w/v) and incubated for 30 minutes at 37°C/5% CO2 in 250 μl of a 1:1000 dilution of goat anti-rabbit IgG Alexafluor 488 (Invitrogen) in binding solution. Cells were washed 4 times with 1 ml PBS/1% BSA (w/v) and fixed for 15 minutes at -20°C in 250 μl of 95% ethanol-5% acetic acid (v/v). The cover slips were removed from the wells, washed in Milli Q H2O and mounted onto glass slides with Vectashield-DAPI (Vector Laboratories, Peterborough, UK) mounting medium. The coverslips were examined using an Axiovert 200M (Zeiss, Welwyn Garden City, UK) confocal microscope. Experiment was performed on three independent occasions and at least 50 cells were examined per experiment.
FACScan analysis of MBP-fusion protein binding to HEp-2 cells
A similar methodology was used as for the fluorescence microscopy as described previously , with the following modifications. The cells were grown directly in 6-well plates at 7 × 105 cells/well. The Alexafluor 488 anti-rabbit IgG antibody was diluted to 1:5000 in PBS/1% BSA (w/v). Cells were resuspended in PBS/0.5% EDTA (w/v) and transferred to BD Falcon 5 ml tubes (VWR, Lutterworth, UK). Cells were washed once with PBS/1% BSA (w/v) and centrifuged, then were fixed for 5 minutes on ice in 2% paraformaldehyde/PBS (w/v). The cells were washed once with PBS/1% BSA (w/v), centrifuged and then were resuspended in 500 μl PBS/1% BSA/0.02% EDTA (w/v). The fluorescence was measured using a FACScan machine (Becton Dickinson, Oxford, UK). Experiment was performed on two independent occasions and 20,000 cells were examined for fluorescence from each sample.
Analysis of co-localisation of MBP-fusion protein and the receptors CD59 and β1 integrin on HEp-2 cells by fluorescence microscopy
A similar methodology was used as for the fluorescence microscopy described above with the following modifications. After the MBP-fusion protein incubation the cells were washed 5 times with PBS then incubated with 250 μl of a 1:20 dilution rabbit anti-Ifp (CovalAb, this study) and 1:1000 dilution of mouse anti-CD59 (Invitrogen) or a 1:1000 dilution of mouse anti-β1 integrin in binding solution for 30 minutes at 37°C/5% CO2. The cells were washed 5 times with 1 ml PBS then incubated with 250 μl of a 1:1000 dilution of goat anti-rabbit IgG Alexafluor 594 (Invitrogen) and 1:1000 dilution of goat anti-mouse IgG Alexafluor 488 (Invitrogen) for 30 minutes at 37°C/5% CO2. The cells were washed 5 times with 1 ml PBS then fixed for 30 minutes at 4°C with 250 μl 2% paraformaldehyde (w/v). The coverslips were removed from the wells, washed with PBS then mounted onto glass slides with Vectashield-DAPI mounting medium (Vector Laboratories). The slides were examined using an Axiovert 200 M confocal microscope (Zeiss). At least three areas of approximately 10 cells each were examined per sample and the experiment was performed on three independent occasions.
Construction of ifp and inv insertional mutants
An ifp knockout mutant was generated in the Y. pseudotuberculosis strain IP32953, after initially constructing an ifp mutant in strain YPIII. Briefly, 1725 bp of ifp was amplified with IntA and IntB primers, digested with SacI and SphI then ligated into the cloning vector pGEM-T easy. The plasmid was digested with BglII to linearise and allow for the ligation of the kanamycin cassette within the ifp sequence. PCR with primers IntA and IntB was undertaken on the plasmid to create linear fragments of kanamycin cassette flanked by ifp sequence. This PCR product was electroporated into YPIII previously transformed with pKOBEG, which contains the λ red recombinase operon. The temperature sensitive pKOBEG plasmid was then lost from putative mutants by growth at 37°C, whilst the presence of the pYV plasmid was maintained by the addition of 2.5 mM CaCl2. Southern blot analysis confirmed correct mutation. Genomic DNA from this YPIIIΔifp was used as a template for PCR amplification of the kanamycin cassette flanked by two ~500 bp regions of gene-specific DNA. The primers INTA and INTB (Table 2) were used to amplify a 2.7 kbp product. This was purified using a Qiagen PCR purification kit, precipitated, and then resuspended in 5 μl MilliQ H2O. Strain IP32953 containing the mutagenesis plasmid pAJD434  was grown in LB broth containing 100 μg trimethoprim ml-1 and 0.8% arabinose (w/v) for 5 hours at 28°C in order to induce the expression of the λ-red genes from the pAJD434 plasmid. These cells were electroporated with the purified PCR product and kanamycin resistant colonies were screened by PCR and Southern blot to confirm the correct insertion. The pAJD434 plasmid was then removed by incubation overnight at 37°C in the presence of 2.5 mM CaCl2. Colonies were screened to confirm the loss of the pAJD434 plasmid and the presence of the virulence plasmid (pYV). A similar method was used for the construction of the inv mutant except primers YPTB1668Chlor1 and YPTB1668Chlor4 (Table 2), were designed to amplify the chloramphenicol resistant cassette from pBAD33 flanked by 50 bp gene-specific regions. This PCR product was then used as described above to generate an insertional mutant of the inv gene (IPΔINV) and a double ifp and inv insertional mutant (IPΔIFPΔINV), by electroporation into IP32953 WT or mutated ifp (IPΔIFP) strains. Colonies were screened as above with inv specific primers and the presence of pYV and loss of pAJD434 was confirmed.
Construction of ifp complement in pBAD33 plasmid
The ifp gene including native promoter was amplified by PCR using specific primers INTPROM3 + INTPROM4 (Table 2). After ligation into pGEM-T Easy vector (Promega) the construct was transformed into XL2-Blue E. coli (Stratagene, La Jolla, USA). The construct was screened by PCR and sequenced, before the ifp gene with promoter was digested from the pGEM-T Easy vector with KpnI and SphI and purified by gel extraction using a Gen Elute purification kit (Sigma). This insert was cloned into a pBAD33 plasmid , also digested with KpnI and SphI and transformed into TOP10 E. coli (Invitrogen). These colonies were again screened by PCR and by digestion with EcoRV to confirm the correct insert and orientation within the pBAD33 vector. IPΔIFP cells were made competent by washing 3 times in 10 ml ice cold H2O and electroporated with pBAD33ifp (pIFP) plasmid to generate an ifp mutant with a complemented ifp gene (IPΔIFPpIFP). These were screened by PCR and were DNA sequenced again to confirm the presence of the correct complemented gene.
Plasmid cured strains
Wild type, defined mutants and ifp complemented mutant strains lacking the pYV plasmid were generated by culturing strains overnight at 37°C the selecting for white colonies on CRMOX plates . Loss of pYV was verified by PCR and repeated screening on CRMOX.
Adhesion and invasion of HEp-2 cells
HEp-2 cells were cultured overnight at 37°C 5% CO2 on coverslips in 24-well plates at 2 × 105 cells/well in 1 ml tissue culture medium. The 10 ml LB broth cultures of IP32953 wild type (IPWT), defined mutants (IPΔIFP, IPΔINV, IPΔIFPΔINV) and mutant with complemented ifp (IPΔIFPpIFP), were incubated at 37°C for 14 hours with appropriate antibiotics and 2.5 mM CaCl2. The cells were washed 3 times with 1 ml PBS and then, at a multiplicity of infection (MOI) of 70:1, incubated for 1 hour with 1 ml of bacterial culture in MEM media at 37°C, 5% CO2. Inoculum was plated on LB agar to determine number of colony forming units (cfu). The cells were washed 5 times with 1 ml PBS and then fixed with 2% paraformaldehyde (w/v) for 45 minutes at 4°C, before being washed again 5 times with 1 ml PBS. The coverslips were incubated with a 1:500 dilution of anti-Yersinia pseudotuberculosis antibody (Abcam, Cambridge, UK) in PBS for 45 minutes at room temperature. The coverslips were washed with PBS then incubated with a 1:1000 dilution of anti-rabbit IgG Alexafluor 488 (green) (Invitrogen) in PBS for 45 minutes at room temperature. After washing with PBS the cells were permeabilised with 0.1% Triton X100-PBS (v/v) for 20 minutes at room temperature. The coverslips were washed with PBS and incubated with 1:500 dilution of anti-Y. pseudotuberculosis antibody (Abcam) in PBS for 45 minutes at room temperature, before being washed again with PBS. Anti-rabbit IgG Alexafluor 594 (red) (Invitrogen) was diluted 1:1000 in PBS and the coverslips were incubated for 45 minutes at room temperature. The coverslips were washed with PBS and mounted onto slides with Vectorshield-DAPI mounting media (Vector Laboratories). Slides were examined by Axiovert 200 M (Zeiss) confocal microscope. Three coverslips per strain with 100 HEp-2 cells per coverslip were counted, utilising the z stack images to gain a 3D representation of the cell. Adhesion and invasion were quantified by counting invaded (red) and adhered (red/green) bacteria and calculating percentage adhesion or invasion per HEp-2 cell based on known MOI. This adhesion and invasion assay was performed on at least three independent occasions.
Detection of the presence of invasin by western blot
Strains were cultured for 15 hours at 28°C and 37°C, the OD600 nm measured and cultures adjusted so all strains had equal quantities of bacteria/ml. Strains were run on a SDS-PAGE 12% Bis-Tris gel, blotted onto nitrocellulose membrane and blocked with 5% milk-PBS-0.1% Tween20. Invasin was visualised by staining with anti-invasin monoclonal antibody  at 1:10000 and anti-rabbit IgG peroxidase conjugate (Sigma) secondary antibody at 1:10000.
Galleria mellonella model of infection
G. mellonella larvae were purchased from Livefood UK Ltd (Rooks Bridge, Somerset, UK). Larvae were infected with 106 cfu Y. pseudotuberculosis IP32953WT, IPΔIFP, IPΔINV, IPΔIFPΔINV or IPΔIFPpIFP in 10 μl inocula by micro-injection (25 μl Hamilton syringe, Cole Palmer, London, UK) in the right foremost leg. PBS and no injection controls were used. The larvae were incubated at 37°C and survival at 72 hours post-infection was recorded. Larvae were scored as dead when the colouration changed from normal pale cream to brown and failed to respond even after gentle manipulation with a pipette tip.
Identification of an intimin and invasin-like protein in Y. pseudotuberculosis
Thermoregulated temporal expression of ifp and inv
Ifp binds to localised foci on HEp-2 cells
Adhesion and invasion assays
Galleria model of infection
In this study we investigated the role of a novel Y. pseudotuberculosis adhesin (Ifp), which shows similarity to both invasin and the intimin adhesin of EPEC and EHEC (Figure 1). As invasin and intimin are well characterised virulence determinants, the discovery of a new member in the same family of outer membrane adhesins, is intriguing. The predicted coding sequence for ifp is disrupted in all seven currently sequenced strains of Y. pestis, although it is intact in the four Y. pseudotuberculosis strains sequenced. This disruption is due to an insertion element (IS285) in all Y. pestis strains, with the exception of the atypical 91001 Y. pestis Microtus strain, where it is disrupted by a nonsense mutation [3, 43, 44]. This may suggest that the disruption in this gene in Y. pestis occurred early in the divergence of Y. pestis from Y. pseudotuberculosis and may have been a potentially important step in this evolutionary process. The inv gene of Y. pseudotuberculosis is also disrupted by an insertion element (IS200) in Y. pestis . The reason for the loss of function of invasin and Ifp in Y. pestis is unknown, but given that it does not have an enteric phase in its lifecycle, it is likely to be not required. This follows the "use it or lose it" concept, whereby genes which no longer provide a selective advantage to the bacteria become pseudogenes . The amino acid similarity of Ifp to both invasin and intimin, coupled with its retention in Y. pseudotuberculosis, suggests a putative role for Ifp in adhesion to cells and that Ifp is a new member in the family of surface adhesins together with invasin and intimin.
The C-terminal 280 amino acids of intimin are the functional domain in this adhesin , and two cysteine (C859 and C937; numbering according to EPEC strain E2348/69) and four tryptophan (W776, W795, W881 and W899) residues are conserved between all intimin subtypes. An alignment of the C-terminal region amino acid sequences of α-subtype intimin from EPEC, Y. pseudotuberculosis invasin and Ifp, revealed that both cysteine and three out of the four tryptophan residues were found to be conserved in both Ifp and invasin (Figure 1). Only W776 was not conserved in Ifp and invasin. These cysteine and tryptophan residues are involved in receptor binding by intimin [27, 30] and therefore may have a role in Ifp receptor binding.
We demonstrated direct binding of Ifp using both flow cytometry and fluorescence microscopy, where the MBP-Ifp fusion proteins could bind to HEp-2 cells. By contrast the MBP alone did not bind and the specific cysteine residue mutant MBP-IfpC337G showed greatly reduced levels of binding (Figures 3 and 4). This reduced level of binding with the MBP-IfpC337G shows that the cysteine residue is important to allow Ifp binding. The same cysteine residue is known to be important in both intimin and invasin, through the formation of a disulphide bond [18, 29], therefore it may be that the cysteine has a similar role in Ifp. The width of the FACS fluorescence intensity graph suggests that MBP-Ifp does not bind uniformly to all cells (Figure 3). This was confirmed by confocal microscopy, where the cells which were exposed to the MBP-Ifp fusion protein, showed a pattern of fluorescence of intensely stained localised areas, instead of scattered fluorescence across the cell surface. A similar pattern of adherence was observed when HEp-2 cells were incubated with MBP fusion proteins of intimin and invasin . As invasin is known to bind to β1 integrins and it has been suggested that intimin can bind to β1 integrin [13, 24, 25] co-localisation of Ifp to β1 integrin was investigated (Figure 5B). As no co-localisation was observed it shows that Ifp binds to alternative receptors on the cell surface. Lipid rafts are sphingolipid and cholesterol rich regions of the plasma membrane, into which Tir is thought to be transferred [47, 48]. Additionally uropathogenic E. coli are known to invade via lipid rafts , and Salmonella and Shigella sp. use a type three secretion system to translocate effectors, by binding to cholesterol within lipid rafts . To investigate if MBP-Ifp was binding to a component of these lipid rafts, co-localisation of MBP-Ifp to CD59 was undertaken by confocal microscopy. CD59 was selected as it is known to localise to these micro-domains and could therefore act as a marker. The results show co-localisation of Ifp and CD59, which was reduced with MBP-IfpC337G (Figure 5A), suggesting that there is a putative receptor for Ifp within these lipid rafts. The Ifp receptor within these lipid rafts has yet to be determined, but as not all of the MBP-Ifp co-localised, no conclusions can currently be made as to the exact receptor of Ifp.
Inv is differentially thermoregulated with lower levels being expressed at 37°C compared to 28°C . In comparison, yadA shows maximal expression at 37°C in exponential phase culture, conditions where inv expression is repressed . YadA is a virulence plasmid (pYV) encoded adhesin, known to be involved during the infection of Y. pseudotuberculosis [51–53]. The pattern of inv expression was confirmed by this study, where inv was expressed both at 28°C and 37°C during lag and early log phase culture, although at a greater degree at 28°C (Figure 2). The ifp gene appears to be expressed at 37°C at a later time point in the late log or early stationary phase, when inv expression is reduced. As ifp and yadA are expressed at similar time points and at the same temperature, Ifp may have a similar role to YadA during the infection of Y. pseudotuberculosis . Although inv expression is decreased at a later time point, it still appears to have an effect on the invasion of Y. pseudotuberculosis (Figure 6B); this is despite using stationary phase cultures which had been grown at 37°C. The western blot analysis for presence of invasin under these conditions (Figure 6D), confirmed that although inv may no longer be actively expressed, invasin was still present in the cell and could therefore have a role in invasion of HEp-2 cells.
The invasion and adhesion assays confirmed the microscopy and flow cytometry results, in demonstrating a role for Ifp as an adhesin, as the levels of adhesion were reduced with IPΔIFP in comparison to wild type (Figure 6A). The inv mutant did not show as great a decrease in adhesion as the ifp mutant, but the double mutant showed similar if not a marginally greater reduction in adhesion as IPΔIFP, in comparison to the wild type. Although levels of invasion were significantly affected by IPΔIFP, this may be due to reduced adhesion, suggesting that Ifp is an adhesin. Any differences between IPΔINV and IPΔIFPΔINV were beyond the detection capability of this assay, but it appeared that invasin was the dominant protein involved in the invasion of the HEp-2 cells. Removal of the pYV and therefore the YadA and Yop virulence factors allowed greater distinction of the role of Ifp. Without these extra virulence determinants compensating for the mutation of ifp, the IPΔIFP mutant showed a statistically significant reduction in adhesion compared to IPWT (Figure 6C). This confirms the role of Ifp as an adhesin of Y. pseudotuberculosis.
As G. mellonella possesses an innate immune system with structural and functional similarities to the mammalian innate immune system, it is a useful alternative to the traditional murine yersiniosis infection model, to examine virulence in vivo, especially as unlike the C. elegans model, G. mellonella can be incubated at 37°C [42, 54]. Previous studies with Y. pseudotuberculosis comparing G. mellonella and the murine model, showed that G. mellonella could reflect infection in mammals and therefore could be useful as a higher throughput screen of mutants, before a more in depth analysis was undertaken in the murine model . In this study the G. mellonella model demonstrated a role for Ifp in the pathogenesis of Y. pseudotuberculosis, in particular in concert with invasin, as the double mutant showed a significant increase in survival compared to the wild type (Figure 7). There also appeared to be mild attenuation in virulence with both of the single mutants. This suggests that Ifp, together with invasin, does have a role in virulence of Y. pseudotuberculosis in this infection model.
We have shown the presence of a novel functional adhesin in Y. pseudotuberculosis that has been mutated with an IS element and is presumably non-functional in Y. pestis. Ifp is expressed during late log to early stationary phase at 37°C and demonstrates an ability to bind to HEp-2 cells in vitro, which can be disrupted by mutation of the gene, or even a single cysteine residue. Together with invasin and intimin, Ifp is a new member of a family of outer membrane adhesins that is activated at 37°C and may act at a later stage than invasin during infection.
We are grateful to G. Frankel, Imperial College, London, UK for the intimin advice; E. Carniel, Institut Pasteur, Paris, France for the Y. pseudotuberculosis strain IP32953 and the pKOBEG vector; A. Darwin, NYU School of Medicine, New York, USA for the pAJD434 plasmid; and R. Isberg, Tufts University, Boston, USA for the gift of the anti-invasin monoclonal antibody. We thank DSTL for financial support for this project.
- Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E: Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA. 1999, 96 (24): 14043-14048. 10.1073/pnas.96.24.14043.PubMedPubMed CentralView Article
- Wren BW: The yersiniae - a model genus to study the rapid evolution of bacterial pathogens. Nat Rev Microbiol. 2003, 1 (1): 55-64. 10.1038/nrmicro730.PubMedView Article
- Chain PS, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, Regala WM, Georgescu AM, Vergez LM, Land ML, Motin VL, et al: Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci USA. 2004, 101 (38): 13826-13831. 10.1073/pnas.0404012101.PubMedPubMed CentralView Article
- Hinchliffe SJ, Isherwood KE, Stabler RA, Prentice MB, Rakin A, Nichols RA, Oyston PC, Hinds J, Titball RW, Wren BW: Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis. Genome Res. 2003, 13 (9): 2018-2029. 10.1101/gr.1507303.PubMedPubMed CentralView Article
- Sokurenko EV, Hasty DL, Dykhuizen DE: Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol. 1999, 7 (5): 191-195. 10.1016/S0966-842X(99)01493-6.PubMedView Article
- Torres AG, Vazquez-Juarez RC, Tutt CB, Garcia-Gallegos JG: Pathoadaptive mutation that mediates adherence of shiga toxin-producing Escherichia coli O111. Infect Immun. 2005, 73 (8): 4766-4776. 10.1128/IAI.73.8.4766-4776.2005.PubMedPubMed CentralView Article
- Day WA, Fernandez RE, Maurelli AT: Pathoadaptive mutations that enhance virulence: genetic organization of the cadA regions of Shigella spp. Infect Immun. 2001, 69 (12): 7471-7480. 10.1128/IAI.69.12.7471-7480.2001.PubMedPubMed CentralView Article
- Sun YC, Hinnebusch BJ, Darby C: Experimental evidence for negative selection in the evolution of a Yersinia pestis pseudogene. Proc Natl Acad Sci USA. 2008, 105 (23): 8097-8101. 10.1073/pnas.0803525105.PubMedPubMed CentralView Article
- Erickson DL, Jarrett CO, Callison JA, Fischer ER, Hinnebusch BJ: Loss of a biofilm-inhibiting glycosyl hydrolase during the emergence of Yersinia pestis. J Bacteriol. 2008, 190 (24): 8163-8170. 10.1128/JB.01181-08.PubMedPubMed CentralView Article
- Rosqvist R, Skurnik M, Wolf-Watz H: Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature. 1988, 334 (6182): 522-524. 10.1038/334522a0.PubMedView Article
- Bliska JB, Copass MC, Falkow S: The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells. Infect Immun. 1993, 61 (9): 3914-3921.PubMedPubMed Central
- Isberg RR, Falkow S: A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature. 1985, 317 (6034): 262-264. 10.1038/317262a0.PubMedView Article
- Isberg RR, Leong JM: Multiple β1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell. 1990, 60 (5): 861-871. 10.1016/0092-8674(90)90099-Z.PubMedView Article
- Clark MA, Hirst BH, Jepson MA: M-cell surface β1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect Immun. 1998, 66 (3): 1237-1243.PubMedPubMed Central
- Hamburger ZA, Brown MS, Isberg RR, Bjorkman PJ: Crystal structure of invasin: a bacterial integrin-binding protein. Science. 1999, 286 (5438): 291-295. 10.1126/science.286.5438.291.PubMedView Article
- Leong JM, Fournier RS, Isberg RR: Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein. Embo J. 1990, 9 (6): 1979-1989.PubMedPubMed Central
- Chen HD, Frankel G: Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev. 2005, 29 (1): 83-98. 10.1016/j.femsre.2004.07.002.PubMedView Article
- Frankel G, Candy DC, Everest P, Dougan G: Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and enterohemorrhagic Escherichia coli, Citrobacter freundii, and Hafnia alvei. Infect Immun. 1994, 62 (5): 1835-1842.PubMedPubMed Central
- Kelly G, Prasannan S, Daniell S, Fleming K, Frankel G, Dougan G, Connerton I, Matthews S: Structure of the cell-adhesion fragment of intimin from enteropathogenic Escherichia coli. Nat Struct Biol. 1999, 6 (4): 313-318. 10.1038/7545.PubMedView Article
- Jerse AE, Kaper JB: The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid. Infect Immun. 1991, 59 (12): 4302-4309.PubMedPubMed Central
- Deibel C, Kramer S, Chakraborty T, Ebel F: EspE, a novel secreted protein of attaching and effacing bacteria, is directly translocated into infected host cells, where it appears as a tyrosine-phosphorylated 90 kDa protein. Mol Microbiol. 1998, 28 (3): 463-474. 10.1046/j.1365-2958.1998.00798.x.PubMedView Article
- Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB: Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell. 1997, 91 (4): 511-520. 10.1016/S0092-8674(00)80437-7.PubMedView Article
- Knutton S, Baldwin T, Williams PH, McNeish AS: Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun. 1989, 57 (4): 1290-1298.PubMedPubMed Central
- Sinclair JF, Dean-Nystrom EA, O'Brien AD: The established intimin receptor Tir and the putative eucaryotic intimin receptors nucleolin and β1 integrin localize at or near the site of enterohemorrhagic Escherichia coli O157:H7 adherence to enterocytes in vivo. Infect Immun. 2006, 74 (2): 1255-1265. 10.1128/IAI.74.2.1255-1265.2006.PubMedPubMed CentralView Article
- Frankel G, Lider O, Hershkoviz R, Mould AP, Kachalsky SG, Candy DC, Cahalon L, Humphries MJ, Dougan G: The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to β1 integrins. J Biol Chem. 1996, 271 (34): 20359-20364. 10.1074/jbc.271.34.20359.PubMedView Article
- Sinclair JF, O'Brien AD: Intimin types α, β, and γ bind to nucleolin with equivalent affinity but lower avidity than to the translocated intimin receptor. J Biol Chem. 2004, 279 (32): 33751-33758. 10.1074/jbc.M401616200.PubMedView Article
- Reece S, Simmons CP, Fitzhenry RJ, Batchelor M, Hale C, Matthews S, Phillips AD, Dougan G, Frankel G: Mutagenesis of conserved tryptophan residues within the receptor-binding domain of intimin: influence on binding activity and virulence. Microbiology. 2002, 148 (Pt 3): 657-665.PubMedView Article
- Frankel G, Candy DC, Fabiani E, Adu-Bobie J, Gil S, Novakova M, Phillips AD, Dougan G: Molecular characterization of a carboxy-terminal eukaryotic-cell-binding domain of intimin from enteropathogenic Escherichia coli. Infect Immun. 1995, 63 (11): 4323-4328.PubMedPubMed Central
- Leong JM, Morrissey PE, Isberg RR: A 76-amino acid disulfide loop in the Yersinia pseudotuberculosis invasin protein is required for integrin receptor recognition. J Biol Chem. 1993, 268 (27): 20524-20532.PubMed
- Batchelor M, Prasannan S, Daniell S, Reece S, Connerton I, Bloomberg G, Dougan G, Frankel G, Matthews S: Structural basis for recognition of the translocated intimin receptor (Tir) by intimin from enteropathogenic Escherichia coli. Embo J. 2000, 19 (11): 2452-2464. 10.1093/emboj/19.11.2452.PubMedPubMed CentralView Article
- Riley G, Toma S: Detection of pathogenic Yersinia enterocolitica by using congo red-magnesium oxalate agar medium. J Clin Microbiol. 1989, 27 (1): 213-214.PubMedPubMed Central
- Atkinson S, Chang CY, Patrick HL, Buckley CM, Wang Y, Sockett RE, Camara M, Williams P: Functional interplay between the Yersinia pseudotuberculosis YpsRI and YtbRI quorum sensing systems modulates swimming motility by controlling expression of flhDC and fliA. Mol Microbiol. 2008
- Maxson ME, Darwin AJ: Identification of inducers of the Yersinia enterocolitica phage shock protein system and comparison to the regulation of the RpoE and Cpx extracytoplasmic stress responses. J Bacteriol. 2004, 186 (13): 4199-4208. 10.1128/JB.186.13.4199-4208.2004.PubMedPubMed CentralView Article
- Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation, and high-level expression by vectors containing the arabinose pBAD promoter. J Bacteriol. 1995, 177 (14): 4121-4130.PubMedPubMed Central
- Dersch P, Isberg RR: A region of the Yersinia pseudotuberculosis invasin protein enhances integrin-mediated uptake into mammalian cells and promotes self-association. Embo J. 1999, 18 (5): 1199-1213. 10.1093/emboj/18.5.1199.PubMedPubMed CentralView Article
- Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice MB, Sebaihia M, James KD, Churcher C, Mungall KL, et al: Genome sequence of Yersinia pestis, the causative agent of plague. Nature. 2001, 413 (6855): 523-527. 10.1038/35097083.PubMedView Article
- Needleman SB, Wunsch CD: A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol. 1970, 48 (3): 443-453. 10.1016/0022-2836(70)90057-4.PubMedView Article
- Isberg RR, Swain A, Falkow S: Analysis of expression and thermoregulation of the Yersinia pseudotuberculosis inv gene with hybrid proteins. Infect Immun. 1988, 56 (8): 2133-2138.PubMedPubMed Central
- Munro S: Lipid rafts: elusive or illusive?. Cell. 2003, 115 (4): 377-388. 10.1016/S0092-8674(03)00882-1.PubMedView Article
- Clark L, Martinez-Argudo I, Humphrey TJ, Jepson MA: GFP plasmid-induced defects in Salmonella invasion depend on plasmid architecture, not protein expression. Microbiology. 2009, 155 (Pt 2): 461-467.PubMedView Article
- Seed KD, Dennis JJ: Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect Immun. 2008, 76 (3): 1267-1275. 10.1128/IAI.01249-07.PubMedPubMed CentralView Article
- Champion OL, Cooper IA, James SL, Ford D, Karlyshev A, Wren BW, Duffield M, Oyston PC, Titball RW: Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis. Microbiology. 2009, 155 (Pt 5): 1516-1522.PubMedView Article
- Lerat E, Ochman H: Recognizing the pseudogenes in bacterial genomes. Nucleic Acids Res. 2005, 33 (10): 3125-3132. 10.1093/nar/gki631.PubMedPubMed CentralView Article
- Song Y, Tong Z, Wang J, Wang L, Guo Z, Han Y, Zhang J, Pei D, Zhou D, Qin H, et al: Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans. DNA Res. 2004, 11 (3): 179-197. 10.1093/dnares/11.3.179.PubMedView Article
- Simonet M, Riot B, Fortineau N, Berche P: Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv gene. Infect Immun. 1996, 64 (1): 375-379.PubMedPubMed Central
- Pallen MJ, Wren BW: Bacterial pathogenomics. Nature. 2007, 449 (7164): 835-842. 10.1038/nature06248.PubMedView Article
- Simons K, Ikonen E: Functional rafts in cell membranes. Nature. 1997, 387 (6633): 569-572. 10.1038/42408.PubMedView Article
- Hayward RD, Hume PJ, Humphreys D, Phillips N, Smith K, Koronakis V: Clustering transfers the translocated Escherichia coli receptor into lipid rafts to stimulate reversible activation of c-Fyn. Cell Microbiol. 2009, 11 (3): 433-441. 10.1111/j.1462-5822.2008.01265.x.PubMedView Article
- Baorto DM, Gao Z, Malaviya R, Dustin ML, van der Merwe A, Lublin DM, Abraham SN: Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature. 1997, 389 (6651): 636-639. 10.1038/39376.PubMedView Article
- Hayward RD, Cain RJ, McGhie EJ, Phillips N, Garner MJ, Koronakis V: Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol Microbiol. 2005, 56 (3): 590-603. 10.1111/j.1365-2958.2005.04568.x.PubMedView Article
- Eitel J, Dersch P: The YadA protein of Yersinia pseudotuberculosis mediates high-efficiency uptake into human cells under environmental conditions in which invasin is repressed. Infect Immun. 2002, 70 (9): 4880-4891. 10.1128/IAI.70.9.4880-4891.2002.PubMedPubMed CentralView Article
- Hudson KJ, Bouton AH: Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection. Infect Immun. 2006, 74 (11): 6487-6490. 10.1128/IAI.00718-06.PubMedPubMed CentralView Article
- El Tahir Y, Skurnik M: YadA, the multifaceted Yersinia adhesin. Int J Med Microbiol. 2001, 291 (3): 209-218. 10.1078/1438-4221-00119.PubMedView Article
- Mowlds P, Kavanagh K: Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans. Mycopathologia. 2008, 165 (1): 5-12. 10.1007/s11046-007-9069-9.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.